Entera Bio Ltd.
Cash Flow Statement
| Line Item | FY2017 | FY2016 |
|---|---|---|
| Operating Activities | ||
| Net Income | $-11.2M | $-1.2M |
| Depreciation & Amortization | — | — |
| Depreciation | — | — |
| Amortization | — | — |
| Stock-Based Compensation | — | — |
| Net Cash from Operating Activities | $-4.5M | $-3.1M |
| Investing Activities | ||
| Capital Expenditures | $51.0K | $41.0K |
| Business Acquisitions | — | — |
| Net Cash from Investing Activities | $1.0M | $-1.1M |
| Financing Activities | ||
| Dividends Paid | — | — |
| Stock Repurchases | — | — |
| Net Cash from Financing Activities | $11.1M | $7.2M |
| Net Change in Cash | $7.6M | $3.0M |
| Free Cash Flow | $-4.6M | $-3.2M |